Dianthus Therapeutics | MGTA - Kewajiban Lancar





Kewajiban Lancar Perubahan Tanggal
Akebia Therapeutics USD 173.88M 10.95M 2026-03
Alaunos Therapeutics USD 595K 218K 2026-03
Avita Medical AUD 62.68M 77K 2025-12
Celltrion KRW 292.71B 9.09B 2026-03
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Dianthus Therapeutics USD 38.28M 7.55M 2026-03
Divis Laboratories Ltd INR 20.43B 3.15B 2026-03
IQVIA Holdings USD 8.33B 9M 2026-03
Kangmei Pharma CNY 5.38B 433.79M 2026-03
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Moderna USD 2.4B 408M 2026-03
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Organigram Holdings CAD 88.74M 5.31M 2026-03
Organon & Co USD 2.5B 110M 2026-03
Ovoca Bio EUR 186K 2.26M 2025-06
Pharma Mar EUR 89.23M 4.65M 2026-03
Qiagen NV USD 512.14M 461.26M 2025-12
Revvity USD 1.24B 92.6M 2026-03
Sartorius EUR 2.11B 145.8M 2026-03
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Tectonic Therapeutic USD 12.96M 3.29M 2026-03
Tilray USD 259.32M 8.32M 2025-09
Viatris USD 6.81B 284M 2026-03
Xeris Pharmaceuticals USD 118.59M 9.02M 2026-03
Zealand Pharma A/S 664.96M 513.61M 2025-12
Zz Pientze Pharmaceu CNY 2.28B 134.52M 2026-03